NCT03608761View on ClinicalTrials.gov

Comparison Between Rebamipide 2% Versus Autologous Serum

PHASE4CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 6, 2017

Primary Completion Date

October 9, 2017

Study Completion Date

July 9, 2018

Conditions
Dry Eye SyndromesSjögren Syndrome
Interventions
DRUG

Rebamipide

rebamipide 2%

BIOLOGICAL

autologous serum

AS for 3 months

OTHER

autologous serum and rebamipide 2%

rebamipide and autologous serum for 3 months

Trial Locations (1)

1684

Hospital Nacional Profesor A. Posadas, El Palomar

All Listed Sponsors
lead

Hospital Nacional Profesor Alejandro Posadas

OTHER

NCT03608761 - Comparison Between Rebamipide 2% Versus Autologous Serum | Biotech Hunter | Biotech Hunter